monoclonal antibody
3-Drug Regimen With 2 Biologics Deployed in High-Risk Crohn’s Trial
San Diego—For the treatment of Crohn’s disease, the combination of two monoclonal antibodies targeting ...
SEPTEMBER 13, 2022
JAK Inhibitors, IL-6 Blockers for COVID-19: Where Do They Fit?
Another JAK inhibitor appears effective in reducing death and respiratory failure in patients hospitalized with ...
JULY 11, 2021
Therapy in Phase 3 Trial Might Be First For Eosinophilic Gastritis
A novel drug alleviated inflammation and symptoms of eosinophilic gastritis and eosinophilic duodenitis in a ...
SEPTEMBER 16, 2020
Load more